Surgery Partners, Inc. (SGRY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Surgery Partners, Inc. (SGRY) is down 12.6% since the beginning of the year. At $14 per share, SGRY is trading 43.9% below its 52-week high of $24. Investors who bought $1,000 worth of SGRY shares 5 years ago would now be looking at an investment worth $223.

Surgery Partners, Inc. (SGRY) has returned -12.56% so far this year and -41.97% over the past 12 months. Over the last ten years, SGRY has returned -0.48% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Oct 1, 2015, SGRY's average daily return is +0.07%, while the average monthly return is +1.61%. At this rate, an investment would double in approximately 3.6 years.

Historically, 52% of months were positive and 48% were negative. The best month was Apr 2020 with a return of +80.7%, while the worst month was Mar 2020 at -60.2%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, SGRY closed higher 48% of trading days. The best single day was Apr 17, 2020 with a return of +47.5%, while the worst single day was Aug 9, 2017 at -36.6%.

Surgery Partners, Inc. has an annualized alpha of -4.97%, beta of 1.58, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since October 02, 2015.

• This stock participated in 196.26% of S&P 500 Index downside but only 151.24% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.19 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SGRY ranks 9 for risk / return — in the bottom 9% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Surgery Partners, Inc. (SGRY) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Surgery Partners, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Surgery Partners, Inc. was 82.86%, occurring on Mar 27, 2026. The portfolio has not yet recovered.

The current Surgery Partners, Inc. drawdown is 79.85%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Surgery Partners, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Surgery Partners, Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.